Mesoblast has had a strong run especially over the last couple of months. Has had a bit of a pullback off its highs so could be well worth a watch to see if it continues back on its upward march. I've set an alert at $3.05 to see what happens.
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.